SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-24-048823
Filing Date
2024-04-18
Accepted
2024-04-18 16:00:06
Documents
17

Document Format Files

Seq Description Document Type Size
1 POS AM tm2411976-1_posam.htm POS AM 693986
2 EXHIBIT 23.3 tm2411976d2_ex23-3.htm EX-23.3 4254
3 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 13180
4 GRAPHIC fc_external-4clr.jpg GRAPHIC 35121
5 GRAPHIC fc_internal-4clr.jpg GRAPHIC 41610
6 GRAPHIC fc_research-4clr.jpg GRAPHIC 46178
7 GRAPHIC bc_mtep-4clr.jpg GRAPHIC 60463
8 GRAPHIC bc_restore-4clr.jpg GRAPHIC 37085
9 GRAPHIC lc_pharmacokinetic-4clr.jpg GRAPHIC 114449
10 GRAPHIC bc_clinicdesign-4clr.jpg GRAPHIC 43581
11 GRAPHIC tb_dosing-4clr.jpg GRAPHIC 32460
12 GRAPHIC lc_peakaims-4clr.jpg GRAPHIC 28295
13 GRAPHIC bc_pdlid-4clr.jpg GRAPHIC 33157
14 GRAPHIC bc_lid-4clr.jpg GRAPHIC 46584
15 GRAPHIC mc_baseline-4clr.jpg GRAPHIC 67610
16 GRAPHIC mc_week-4clr.jpg GRAPHIC 66537
17 GRAPHIC tm2411976d2_ex23-3img001.jpg GRAPHIC 9775
  Complete submission text file 0001104659-24-048823.txt   1615430
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-271611 | Film No.: 24854252
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)